News

Telemedicine Reduces Readmission in Post-PCI ACS Patients

ATLANTA — Patients with acute coronary syndrome (ACS) who had a myocardial infarction or unstable angina and underwent percutaneous coronary intervention (PCI) had a 76% lower rate of hospital readmission after 6 months if they participated in a remote monitoring protocol compared with similar patients who had standard post-discharge care…

Stopping aspirin 1 month after coronary stenting significantly reduces bleeding complications in heart attack patients

Stopping aspirin 1 month after coronary stenting significantly reduces bleeding complications in heart attack patients

The primary efficacy endpoint of clinically-relevant bleeding, defined as BARC types 2, 3 or 5 bleeding, was assessed in the intention-to-treat population between one-month and twelve-months post-PCI in patients who were event-free after one month of ticagrelor and aspirin. Switching to ticagrelor monotherapy at one month resulted in a 55-percent reduction in the hazard of

Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells

Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells

The results of a pioneering study support the safety of the bioimplants called PeriCord, made from stem cells of the umbilical cord and pericardium from a tissue donor, which aid in the regeneration and revascularization of the affected area. The study has monitored seven interventions of this pioneering tissue engineering surgery over three years…

Genetic Testing of Some Patients With Early-Onset AF Advised

Genetic testing may be considered in patients with early-onset atrial fibrillation (AF), particularly those with a positive family history and lack of conventional clinical risk factors, because specific genetic variants may underlie AF as well as “potentially more sinister cardiac conditions,” a new white paper from the Canadian Cardiovascular Society suggested…

Long-distance and low-attenuation magnetic energy focusing technology for deep-tissue wireless powering

Long-distance and low-attenuation magnetic energy focusing technology for deep-tissue wireless powering

Editors’ notes This article has been reviewed according to Science X’s editorial process and policies. Editors have highlighted the following attributes while ensuring the content’s credibility: fact-checked trusted source proofread by Science China Press (a1) System design of the ULFMEF developed for wireless charging of implantable electronic devices, where the ULFMEF system consisted of an IMER